Efficacy of 3,4-diaminopyridine in the treatment of Lambert-Eaton myasthenia syndrome
Not Applicable
Completed
- Conditions
- ambert-Eaton myasthenia syndrome
- Registration Number
- JPRN-jRCT1091220208
- Lead Sponsor
- Hiroyuki FUKUDA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 3
Inclusion Criteria
Clinically confirmed Lambert-Eaton myasthenia patients who have muscle weakness
Exclusion Criteria
Poor PS
GOT,GPT>100
BUN>30,Cr>2.0
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method